Oncology Ventures

Check this investor

23 founders have viewed this investor
Fund vehicles on file

Oncology Ventures has 4 venture fund vehicles on file with the SEC, run from Boca Raton, Florida, with first sales running from 2023 to 2026. 6 Form D notices, originals and amendments, have been filed for them, the first on April 25, 2023 and the latest on March 19, 2026. Together they have taken in $80,803,000 from 255 investor positions, most recently on January 30, 2026. The smallest investment any of them will accept is $10,000. 4 vehicles are still showing room to take more.

Vehicles44 still open
Closed$80.8M$80,803,000
Target$180M1 uncapped, excluded
Since last close264dJanuary 30, 2026
Vehicle Vintage Target Closed Remaining First sale Days Min check LPs Status
Oncology Ventures Fund II LP
Limited Partnership · Delaware-organised
2026 $70M $42.3M $27.7M January 30, 2026 264 — 99 open
Oncology Ventures Fund II-A LP
Limited Partnership · Delaware-organised
2026 $70M $12.3M $57.7M January 30, 2026 264 — 50 open
Oncology Ventures Fund I-A LP
Limited Partnership · Delaware-organised
2024 no cap set $5M — April 30, 2024 904 $10K 37 open
ONCOLOGY VENTURES FUND I LP
Limited Partnership · Delaware-organised
2023 $40M $21.2M $18.8M April 28, 2023 1,272 $10K 69 open amended
People named in the fund filings

The filings for these vehicles name one person or entity, with the role each filing gives.

Related investors
All investors with a sourced record →
Vetting this investor? Get the free Snapshot → Order Full Report on Oncology Ventures → Get warm-intro paths to Oncology Ventures → See how VCs use MentionFox →

Tools for this story

Each opens in a new tab, filled in for Oncology Ventures. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/investors/oncology-ventures
Last updated 2026-03-19
Oncology Ventures: venture fund vehicles on file. MentionFox, 2026-03-19. https://mentionfox.com/investors/oncology-ventures
Public profile · MentionFox — investor research, warm-intro mapping, and full reports.